84877-0
ClinicalSynchronous tumor site Cancer
Definition
Patients presenting with more than one histologically distinct malignancy may be classified as having synchronous tumors. Multiple primary malignancies (MPMs) are divided into 2 categories: 'synchronous', when tumors arise independently and within 6 months from the primary malignant tumor or 'metachronous', when the interval is longer (greater than 6 months). This term is used to report the location of the other synchronous tumor(s). This term was created for, but not limited in use to, the Colorectal Cancer Structured Reporting Protocol (2nd Edition, 2012) developed by the Royal College of Pathologists of Australasia (RCPA).
LOINC 6-Axis Classification
Component
Synchronous tumor site
Property
Anat
Time Aspect
Pt
System
Cancer.XXX
Scale Type
Nom
Method Type
N/A
Details
Class
ONCOLOGY
Order/Observation
Observation
Short Name
Synchronous tumor site Cancer
Related Names
Frequently Asked Questions
What is LOINC code 84877-0?
LOINC code 84877-0 identifies "Synchronous tumor site Cancer". Patients presenting with more than one histologically distinct malignancy may be classified as having synchronous tumors. Multiple primary malignancies (MPMs) are divided into 2 categories: 'synchronous', when tumors arise independently and within 6 months from the primary malignant tumor or 'metachronous', when the interval is longer (greater than 6 months). This term is used to report the location of the other synchronous tumor(s). This term was created for, but not limited in use to, the Colorectal Cancer Structured Reporting Protocol (2nd Edition, 2012) developed by the Royal College of Pathologists of Australasia (RCPA).
What does 84877-0 measure?
This code measures Synchronous tumor site in Cancer.XXX. It belongs to the ONCOLOGY class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.